Drug Usage Statistics, United States, 2007 - 2017

Number of Prescriptions Over Time (2007 - 2017)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2007 27  4
2008 47  20
2009 55  8
2010 75  20
2011 103  28
2012 103 0
Year Rank Change
2013 117  14
2014 142  25
2015 137  5
2016 141  4
2017 188  47

Patient Out-Of-Pocket Cost Over Time (2007 - 2017)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2017)
Omeprazole 58,837,875
Pantoprazole Sodium 27,081,978
Esomeprazole 9,036,551
Lansoprazole (this drug) 3,109,063
Dexlansoprazole 2,696,881
Rabeprazole Sodium 1,445,283

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Prevacid
  • Prevacid 24 HR
  • Prevacid IV
Generic Drug Synonyms and Salts
  • Lansoprazole

FDA Approval Information

Established Pharmacologic Class (EPC): Proton Pump Inhibitor
Initial FDA approval date: 5/10/1995
First FDA applicant: Rx
First dosage form: Capsule, Delayed Rel Pellets (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2007-2017. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 20.1. Read more about the ClinCalc DrugStats database.


Related Links

Follow Us!

New and Popular


Open Menu

Cite This Page

Show AMA citation

ICU Trials: Summarized critical care trials at your fingertips
©2020 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jul 19, 2018
Back to Top